Related Experiment Video
Updated: Dec 25, 2025

Analysis of 18FDG PET/CT Imaging as a Tool for Studying Mycobacterium tuberculosis Infection and Treatment in Non-human Primates
Published on: September 5, 2017
Ending TB in Southeast Asia: current resources are not enough
Vineet Bhatia1, Rahul Srivastava1, K Srikanth Reddy2
1Department of Communicable Diseases, World Health Organization Regional Office for South-East Asia, New Delhi, India.
Increased investment is crucial to combat tuberculosis (TB) in Southeast Asia. Doubling spending on TB prevention, diagnosis, and treatment is essential to achieve elimination goals and prevent severe health and economic consequences.
Area of Science:
- Public Health
- Epidemiology
- Health Economics
Background:
- Tuberculosis (TB) poses a severe health and development challenge in Southeast Asia.
- Uncontrolled TB burdens socioeconomic development and fuels drug resistance.
- Current investment levels are insufficient to meet TB elimination targets.
Purpose of the Study:
- To delineate resource needs, availability, and gaps for ending TB in Southeast Asia.
- To estimate the financial investment required to achieve TB elimination targets.
- To inform policy and funding decisions for TB control programs.
Main Methods:
- Utilized epidemiological inputs from a mathematical model.
- Conducted a costing analysis based on WHO country reports and published data.
- Accounted for program and patient costs in funding projections.
Main Results:
- Achieving TB elimination targets requires substantial increases in TB-related spending.
- An estimated US$2 billion annually is needed for TB activities in the region.
- Current spending levels need to nearly double to bend the TB incidence curve.
Conclusions:
- Substantial increases in investment are critical for TB prevention, diagnosis, and treatment in Southeast Asia.
- Failure to increase investment will have catastrophic socioeconomic effects.
- Targeted interventions and increased funding are achievable pathways to ending TB.
Related Concept Videos
Pulmonary Tuberculosis V
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Pulmonary Tuberculosis I
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Pulmonary Tuberculosis II
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Pulmonary Tuberculosis IV
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Pulmonary Tuberculosis III
The first classification is based on the development of the disease, and it includes the following categories:
Transmission-based Precautions II: Airborne and Protective Environment
Airborne precautions:
Use airborne precautions when treating patients known or suspected to have diseases that spread through the air—for example, tuberculosis or measles. These organisms are present in smaller droplets expelled by an infected person and...

